SCHEMBL11268602

SCHEMBL11268602

Nc1ccc(Cl)cc1NCc1ccc(F)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OXTR P30559 1/20 0.49
AVPR1A P37288 1/20 0.49
MEN1 O00255 3/20 0.46
KMT2A Q03164 3/20 0.46
ALDH1A1 P00352 3/20 0.46
POLB P06746 3/20 0.44
CISD1 Q9NZ45 1/20 0.43
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C19 P33261 1/20 0.42
MAPT P10636 2/20 0.42
TP53 P04637 1/20 0.42
ADORA2A P29274 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
VNN1 O95497 2/20 0.42
BRD4 O60885 1/20 0.42
KAT2B Q92831 1/20 0.42
RXFP1 Q9HBX9 1/20 0.41
RAB9A P51151 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11569274 0.87 ALDH1A1 (0.49) OXTRAVPR1AMEN1KMT2AALDH1A1
SCHEMBL7089167 0.83 PKM (0.52) MEN1KMT2AALDH1A1MAPTGAA
SCHEMBL9681343 0.81 HDAC3 (0.44) MEN1KMT2AALDH1A1POLBCISD1
SCHEMBL30643863 0.80 LOXL2 (0.45) ALDH1A1CYP1A2CYP2D6CYP2C19MAPT
SCHEMBL20919482 0.80 LOXL2 (0.45) ALDH1A1CYP1A2CYP2D6CYP2C19MAPT
SCHEMBL14847556 0.77 MAPT (0.43) MEN1KMT2AALDH1A1POLBMAPT
SCHEMBL20715674 0.77 HDAC8 (0.42) MEN1KMT2APOLBCYP1A2CYP2C19
SCHEMBL13559770 0.77 POLB (0.51) MEN1KMT2AALDH1A1POLBCYP1A2
SCHEMBL11964451 0.77 HDAC3 (0.49) ALDH1A1SMN1; SMN2GAALMNAL3MBTL1
SCHEMBL9134263 0.76 HDAC1 (0.49) MEN1KMT2AALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0005318-B1 N-HETEROCYCLYL-4-PIPERIDINAMINES, METHODS FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS COMPRISING THEM, INTERMEDIATES THEREFOR, AND METHOD FOR THE PREPARATION OF THE INTERMEDIATES JANSSEN PHARMACEUTICA N.V. (BE) 1982-01-06 EP disclosed